Antibe Therapeutics (CA.ATE) - 0.9583 CAD (%)

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 0.9656 CAD
Ask 1.1035 CAD
Minim 0.8131 CAD
Maxim 0.9874 CAD
Pret referinta 0.9003
Volum -
Volum ultima zi 1
Max 52 sapt 1.2300 CAD
Min 52 sapt 0.4300 CAD

Descriere companie

Antibe Therapeutics Inc. (http://www.antibethera.com/) is a commercial-stage pharmaceutical company. The Company is focused on pain, inflammation, and regenerative medicine. The Company’s products pipeline includes Otenaproxesul, ATB-352, and ATB-340. Otenaproxesul is a novel anti-inflammatory drug that releases hydrogen sulfide and combines hydrogen sulfide with naproxen, non-steroidal, anti-inflammatory drug. ATB-352 is a hydrogen sulfide-releasing derivative of ketoprofen. ATB-340 is a gastrointestinal-safe version of low-dose aspirin for cardiovascular and cancer protection. The Company, through its wholly owned subsidiary, Citagenix Inc. (Citagenix) is a seller of tissue regenerative products servicing the orthopaedic and dental marketplaces. Citagenix’s portfolio consists of branded biologics and medical devices that promote bone regeneration.

Informatii companie

Nume

Antibe Therapeutics Inc.

Buna ziua, sunt TreVi. Spuneti-mi, va rog, cu ce informatii va pot fi de folos.